INTRODUCTION
The carbonic anhydrases (CA; EC 4.2.1.1) catalyze the hydration of CO2 and the dehydration of HCO~ and are known to occur in most prokaryotes and eukaryotes that have been examined. Three isozymes of carbonic anhydrase, CA I, CA II, and CA III, which are under the control of separate genetic loci, have now been characterized from vertebrate tissues. CA I (low-activity form) is found mainly in red cells and some other tissues (e.g., rumen epithelium, cecum, colonic mucosa, ciliary body), CA II (high-activity form) is found in red cells and almost all tissues, and CA III (low-activity, sulfonamideresistant form) is found primarily in red skeletal muscle and rat liver (cf. Tashian, 1977; Tashian et al., 1980a,b; Kishida and Ochi, 1980; Carter et al., 1981) . Also, a particulate-bound form of CA has been reported from human kidney (McKinley and Whitney, 1976 ) and a mitochondrial CA has been found in guinea pig skeletal muscle and liver (Dodgson et al., 1980) . These may represent additional isozymes of CA.
Comparisons of the primary structures of various mammalian CA I, CA II, and CA III isozymes show a considerable degree of sequence homology (i.e., about 40% of the residues at the same positions are identical), indicating that these isozymes arose from a common gene by duplications well over 300 million years ago (Tashian et al., 1980a) . Antibodies prepared against a single isozyme will cross-react with varying intensities by immunoprecipitation with the same isozyme from widely separated species (cf. Tashian et al., 1968; Suyama et al., 1968a; Nonno et al., 1969; Fine and Laurent, 1970) . However, immunological cross-reactions have not been detected between isozymes, not even between the highly homologous (about 60%) CA I and CA II sequences of a single mammalian species, e.g., human (cf. Micheli and Buzzi, 1964; Tashian et al., 1968; Suyama et al., 1968b; Fine and Laurent, 1970) . Since only immunoprecipitation procedures have been used in these studies, it seemed probable that cross-reactions would be observed with the use of more sensitive binding assays. We report here the results of such assays in which cross-reactions were observed between various CA isozymes found by the use of a variety of antisera, including monoclonal antisera prepared by the hybridoma technique.
MATERIALS AND METHODS

Purification of Antigens
The CA I and CA II antigens (Table I) were purified from hemolysates by affinity chromatography on sulfonamide (Prontosil) columns as described by Osborne and Tashian (1975) . The CA III antigens were initially prepared Tashian, 1975) on columns equilibrated with 0.01 or 0.005 M Tris-SO4, pH 8.7, and eluted with a 0-0.4 M KI gradient, followed by purification on DEAE-32 cellulose columns equilibrated with 0.01 M Tris-HCI, pH 8.7, and eluted with a 0-0.2 M NaC1 gradient. If necessary, further purification of CA III was carried out by passage through a G-75 Sephadex column equilibrated with 0.05 M Tris-HC1, pH 8.0. The solutions used in the purification of the CA III isozymes contained 0.5 mM dithiothreitol.
Immunizations
Individual anti-CA sera were obtained by immunizing BC8 (C57BL/6. C-Igh") mice with 200 #g of either human CA l, human CA II, or bovine CA III at weekly intervals by the intraperitoneal route. The antigen was diluted with Dulbecco's CA 2+, mg 2+-free phosphate-buffered saline (PBS) so as to be delivered in 0.5 ml in a 50:50 homogenate with Freund's adjuvant, complete for the first injection and incomplete thereafter. A series of four injections was given, followed by a 6-week rest, and the immunization series was terminated with a 50-~g boost given in a similar volume.
BALB/c mice were immunized with a mixture of human CAs I and II and bovine CA III in preparation for producing monoclonal antibodies by the hybridoma technique. The triple immunization allowed us to obtain monoclonal antibodies to more than one isozyme from one fusion. To accomplish this, the mice were given a series of intraperitoneal injections at 2-week intervals of 0.2 ml of a 1:1 carbonic anhydrase (l.8-3.7 mg/ml in PBS):adjuvant solution (a dosage of 0.07-0.17 mg of each antigen). For the initial two injections, complete Freund's adjuvant was used; subsequent injections were done in incomplete Freund's adjuvant. Sera were obtained 2-5 days postinjection by tail bleeding the mice. After the serum titer has reached 1 / 1000 by the antigen immunoadsorption test described below, the mice were given a final intravenous injection of 0.1 ml of a saline solution containing 35 tzg of each antigen. Three days later, their spleens were removed and fused.
Antibody to bovine CA III was prepared in a New Zealand white rabbit by subcutaneous injections of a mixture containing 1 mg purified CA III in 0.8 ml 0.85% saline and 0.8 ml Freund's complete adjuvant. The same procedure (with Freund's incomplete adjuvant) was followed after a period of 3 weeks, with additional injections at weekly intervals for the following 2 weeks. The rabbit was bled 1 week after the last injection.
Production of Monocional Antibodies
The fusion technique was a modification of that described by Gefter et al. (1977) . The specific details can be found elsewhere (Claflin et al., 1981) . Myeloma cells (SP2/O-Ag 14) were grown in suspension in supplemental Dulbecco's modified Eagle (DME) + 15% fetal calf serum. Cells were fused in DMA + 20 mM Hepes buffer, and the fused cells were cloned in Iscove's modified DME (GIBCO, Grand Island, N.Y.) supplemented with 20% fetal calf serum, 10% NCTC 109, 1% Pen-Strep, and 3.024 g of NaHCO3 per liter of solution. Hybrid cells were selected in a HAT medium consisting of the supplemented Iscove's described above with 100 #M hypoxanthine, 10 ~M aminopterin, and 30 izM thymidine (Margulies et al., 1976; Littlefield, 1964) .
Following fusion, the cells were seeded into 96-well cluster dishes (Costar, Cambridge, Mass.), and these dishes were examined for clones. When clones covered 10-20% of the surface area of the wells, supernatants were assayed for the presence of anti-human CA I, anti-human CA II, or antibovine CA III by the absorbed antigen radioimmunoassay.
Radioimlnunoassays
Scrum and hybridoma supcrnatants werc measured by an absorbed antigcn radioimmunoassay previously dcscribed (Klinman, 1972) . Serum or supcrnatant dilutions werc added to polyvinyl chloride microtiter platcs (Cook Laboratory Products Division, Dynatech Laboratories, Inc., Alexandria, Va.) prccoated with 0.2 ml of a 20 /~g/ml antigen solution per wcll, then with 3,-globulin-frcc fetal calf serum (10%) as a source of blocking protcin. After the plates were washed, bound antibody was assayed by the addition of 125I-labelcd anti-mouse IgG or anti-mousc Fab; wells were cut out and counted, using wells coated with 1% BSA in PBS as a control.
Competitive inhibitions bctwcen antigens were performed using an antibody-absorbed solid-phase radioimmunoassay. A dilution of antibody predetermined to give maximal binding of 125I-antigcn was allowcd to adsorb on polyvinyl chloridc microtiter plates for 6 hr at room tempcrature. The wells were washed 2× with PBS-azide (0.01% Na-azide) and allowed to soak for several hours in 1% ovalbumin in PBS-azide at room temperature. The ovatbumin was removed by aspiration and 0.2 ml of a radioactive solution consisting of various dilutions of inhibitors in 1% ovalbumin-PBS containing ~251-CA (30,000 to 60,000 cpm/ml) was added. The microtiter plate was incubated at 37°C overnight in a humidified chamber, washed 3x with PBS-azide, and dried, and each well was cut out and counted.
Radiolabeling
Rabbit anti-mouse IgG (Gateway Immunosera, St. Louis, Mo.) or rabbit anti-mouse Fab (Rudikoff et al., 1972) was labeled with 125I while bound to mouse IgG columns (Herzenberg and Herzenberg, 1978) .
Bovine CA III was iodinated by the iodogen method (Fraker and Speck, 1978) . Briefly, 20/zg of bovine CA II1 was incubated with 200 #Ci Na ~25I for 1 rain at room temperature in a chloroglyeoluril-coated tube in 100 #1 of 0.7 MNaC1, 0.2 M potassium phosphate, pH 7.0. The 125I-CA was separated from Na ~25I on Sephadex G-25 by collection 0.5-ml samples in tubes which already contained a drop of 1% ovalbumin. The two tubes containing the first peak were pooled with rinses of 1% ovalbumin in PBS and then dialyzed for further removal of free NA ~25I. The final specific activity was 0.3 #CI/#g.
RESULTS
The binding of 125I-bovine CA II1 by rabbit anti-bovine CA III serum was strongly inhibited by cold bovine CA III and weakly inhibited by cold human CA I (Fig. 1) . The inhibition by the cross-reacting CA I was 3 orders of magnitude weaker than the autologous reaction and it did not go to completion. Human CA II did not significantly inhibit the binding of bovine CA IlI by its autologous antibody. Cross-reactions of anti-CA antibodies were studied in more detail using direct immunoadsorption of mouse anti-CA antibodies. A number of sera were tested and most showed cross-reactions between isozymes. Several representative patterns are shown in Fig. 2 . Antisera to CA I or CA II frequently reacted nearly as well to the other red blood-cell isozyme as to the autologous antigen, e.g., anti-I in Fig. 2A and anti-II in Fig. 2C . The anti-CA I or II usually also reacted quite well with CA III (even from a different species) (Figs. 2A and C) . Some antisera showed much stronger binding reactions with autologous antigen than with other CA isozymes, e.g., another anti-I in Fig. 2D . Antisera to Ca III were usually weaker than antisera to CA I or II but they frequently showed good cross-reactions with CA I or II, e.g., Fig. 2B demonstrates a cross-reaction of anti-IlI with CA II; similar reactions with CA I were sometimes found (not shown).
We sought to understand further the nature of the cross-reactions between the CA isozymes by using monoclonal antibodies prepared by the hybridoma technique. The fusion of the mice spleen cells with the SP2 myeloma cells resulted in 644 microtiter wells, of which 32 yielded clones, an efficiency rate of 5%. Of these 32 clones, 8 showed anti-carbonic anhydrase a,~,~\ o\ activity (25% of the clones and 1.25% of the total fusion). The reactivity of the hybridoma supernatants was determined by a counting ratio of the reaction of the antibody with the carbonic anhydrase to the antibody with bovine serum albumin:
counting ratio (CR) = cpm 125I-ab-ab-CA cpm ~zSI-ab-ab-BSA"
All the monoclonal supernatants were tested for immunoprecipitation with all three antigens by double diffusion and all were negative as is expected for the reaction of a monoclonal antibody with a monomeric antigen. Table II indicates the cross-reactivity patterns of supernatants from five of the eight positive clones (three lost secretory activity too early for testing). The especially significant results in Table II are italicized. Several interesting patterns are readily seen. Clone 2G-4 reacted well with bovine CA 1II, one of the antigens used to immunize the triply immunized mice, and not at all with any other CA isozymes, including other CA III's. Clone 12C-8 probably originated from the fusion of a spleen cell which had responded to human CA II since the strongest reactions occurred with CA II from three species. A nearly equivalent reaction occurred to human CA I and significant reactions occurred with chicken and rabbit CA III. Clone 2B-7 was presumably also directed against human CA II but reacted more strongly with rhesus CA II than with the autologous antigen. This monoclonal antibody also reacted with some CA llI's. Similarly, clone 10E-3 reacted most strongly with human and rat CA II and moderately with several CA III's. Clone 2D-2 reacted weakly with almost all CA isozymes--the concentration of antibody in this supernatant may have been lower than that with the other clones.
DISCUSSION
The population of antibody molecules resulting from immunization with various poly-oe-amino acids clearly includes many with combining sites interacting with five or six amino acid residues (cf. Arnon et al., 1965; Kabat, 1966; Twining et al., 1980, and references therein) . Thus, the 60% amino acid sequence homology between human CA I and human CA II and their very similar topography by X-ray crystallography (Kannan, 1980) would lead to a prediction of some immunological cross-reactivity. For instance, bovine and guinea pig a-lactalbumins, with about 60% homology in amino acid sequence, show a definite cross-reaction (Erickson and Rosenberg, 1973) . Such crossreactions have probably not been found previously because binding studies of antibodies to carbonic anhydrases have not been previously performed. We found that most polyva!ent rabbit and mouse antisera showed
cross-reactions between CA I and CA II while weaker cross-reactions between CA III and CA I and/or CA li were found. Some of the differences in reactivity suggest that species-specific determinants are also being detected. For instance, anti-human CA I and anti-human CA II react better with human CA I or II than with bovine CA III (Figs. 2A, C, and D) . Similarly, anti-bovine CA III reacts better with the homologous antigen than with the human CA III isozyme (Table II) , Monoclonal antisera raised by the hybridoma technique appeared to detect single haptens (as expected) since the cross-reactions were more individualized: one clone showed cross-reactions between CA II and CA III. Perhaps greater cross-reactions with CA I would have been detected if as many different species examples of CA I had been tested.
Of interest is the observation that several of the monoclonal anticarbonic anhydrase antibodies reacted more strongly with homologous CAs from species other than the immunizing species (Table II) , e.g., 2B-7 reacted fourfold better with rhesus CA II than with the human CA II immunogen. Such idiosyncratic reactions of monoclonal antibodies are also being found in other systems. The recent report of a cross-reaction of anti-Thy 1.1 monoclonal antibody with vimentin was interpreted in terms of a possible shared carbohydrate between vimentin and Thy-1 (Dulbecco et al., ! 981 ). An earlier report (Pillemer and Weismann, 1981) of cross-reaction of an anti-Thy i monoclonal with an anti-phosphorylcholine idiotypic specificity of mouse antibodies was interpreted in terms of possible evolutionary homology of the Thy 1 molecule with antibodies. (Since it is a very low percentage of homology, this degree of cross-reaction would not be expected, however.)
An alternative explanation of these cross-reactions may be the phenomenon of "half-site reactivity." In other words, monoclonal-secreting hybridomas are selected with such sensitive immunoassays that low-affinity antibodies are chosen. As Landsteiner demonstrated some years ago, in studies of artificial haptens, low-avidity antisera show quite wide cross-reactions with heterologous antigens (Landsteiner, 1946) . Since an antibody combining site has a fairly fixed size, antibody production may be elicited to haptens which only partially correspond to the combining site. The potential for antigen binding by antibody when only a portion of the combining site is involved is suggested by fractionation studies of antihapten antibodies which detect some antibodies reacting with subportions of the hapten while others seem to be specific for the larger, total hapten (Pressman and Grossberg, 1973) . This lack of specificity might especially be expected for IgM monoclonals since their maximal association constants, at least in the case of antilactosyl antibodies, are 50-fold lower than those for IgG monoclonals (Mandal and Karush, 1981) .
